NSE:SOLARAPP1 (India)
Â
Ordinary Shares (Partly Paid Rs.7)
₹
267.45
(0%)
Sep 4
Business Description
Solara Active Pharma Sciences Ltd
ISIN : IN9624Z01022
Share Class Description:
NSE:SOLARAPP1: Ordinary Shares (Partly Paid Rs.7)Total Employee Number:
2,924Compare
Compare
Traded in other countries / regions
541540.India IPO Date
2024-06-27Description
Solara Active Pharma Sciences Ltd is an Active Pharmaceutical Ingredients company engaged in the development and manufacture of APIs and providing CDMO services to pharmaceutical companies. The Company operates through six multi-product manufacturing facilities and is engaged in the manufacture and sale of Active Pharma Ingredients. Its products include Anthelmintic, Anticonvulsant, Loop Diuretic, Anxiolytic, Antihistamine, Antipsychotic, Calcimimetic Agent, Antigout Agent, Anti-hyperlipidemic, and others. The Company generates maximum revenue from Asia Pacific.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.08 | |||||
Equity-to-Asset | 0.54 | |||||
Debt-to-Equity | 0.55 | |||||
Debt-to-EBITDA | 3.55 | |||||
Interest Coverage | 0.96 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.25 | |||||
Beneish M-Score | -2.52 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -5.1 | |||||
3-Year EPS without NRI Growth Rate | 64 | |||||
3-Year FCF Growth Rate | 25.4 | |||||
3-Year Book Growth Rate | -12.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.96 | |||||
Quick Ratio | 0.6 | |||||
Cash Ratio | 0.06 | |||||
Days Inventory | 166.39 | |||||
Days Sales Outstanding | 94.14 | |||||
Days Payable | 134.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.2 | |||||
Shareholder Yield % | 4.91 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 48.69 | |||||
Operating Margin % | 6.21 | |||||
Net Margin % | -0.11 | |||||
EBITDA Margin % | 13.53 | |||||
FCF Margin % | 6.99 | |||||
OCF Margin % | 10.68 | |||||
ROE % | -0.13 | |||||
ROA % | -0.07 | |||||
ROIC % | 4.23 | |||||
3-Year ROIIC % | -13.79 | |||||
ROC (Joel Greenblatt) % | 6 | |||||
ROCE % | 6.57 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 8.52 | |||||
PE Ratio without NRI | 883.98 | |||||
Shiller PE Ratio | 741.45 | |||||
PS Ratio | 1.97 | |||||
PB Ratio | 2.46 | |||||
Price-to-Tangible-Book | 3.56 | |||||
Price-to-Free-Cash-Flow | 28.18 | |||||
Price-to-Operating-Cash-Flow | 18.44 | |||||
EV-to-EBIT | 40.98 | |||||
EV-to-EBITDA | 19.23 | |||||
EV-to-Revenue | 2.6 | |||||
EV-to-FCF | 37.21 | |||||
Price-to-GF-Value | 1.1 | |||||
Price-to-Projected-FCF | 3.31 | |||||
Price-to-Graham-Number | 7.65 | |||||
Earnings Yield (Greenblatt) % | 2.44 | |||||
FCF Yield % | 3.24 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Solara Active Pharma Sciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 14,314.3 | ||
| EPS (TTM) (₹) | -0.62 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (₹) | - | ||
| 20-Day SMA (₹) | 267.45 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (₹) | 267.45 - 267.45 | ||
| Shares Outstanding (Mil) | 48.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Solara Active Pharma Sciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Solara Active Pharma Sciences Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2027 | 2027-02-05 16:30 | In 152 days | ||
| Third quarter earnings results for 2027 | 2027-02-05 | In 151 days | ||
| Second quarter earnings conference call for 2027 | 2026-11-05 15:30 | In 60 days | ||
| Second quarter earnings results for 2027 | 2026-11-05 | In 59 days | ||
| General meeting for 2026 | 2026-09-18 10:30 | In 12 days | ||
| Annual report for 2026 | 2026-08-25 | 267.45 (+0.00%) | ||
| First quarter earnings conference call for 2027 | 2026-07-23 16:00 | 267.45 (+0.00%) | ||
| First quarter earnings results for 2027 | 2026-07-23 | 267.45 (+0.00%) | ||
| Fourth quarter earnings conference call for 2026 | 2026-05-15 15:00 | 267.45 (+0.00%) | ||
| Fourth quarter earnings results for 2026 | 2026-05-15 | 267.45 (+0.00%) |
Show
Entries
Solara Active Pharma Sciences Ltd Frequently Asked Questions
What is Solara Active Pharma Sciences Ltd(NSE:SOLARAPP1)'s stock price today?
The current price of NSE:SOLARAPP1 is ₹267.45. The 52 week high of NSE:SOLARAPP1 is ₹267.45 and 52 week low is ₹267.45.
When is next earnings date of Solara Active Pharma Sciences Ltd(NSE:SOLARAPP1)?
The next earnings date of Solara Active Pharma Sciences Ltd(NSE:SOLARAPP1) is 2026-11-05 Est..
Does Solara Active Pharma Sciences Ltd(NSE:SOLARAPP1) pay dividends? If so, how much?
Solara Active Pharma Sciences Ltd(NSE:SOLARAPP1) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Solara Active Pharma Sciences Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers